At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Oculus Go Virtual Reality Gogglesdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Use of Virtual Reality During Breast Localization Procedures
In Brief
A clinical study evaluating Oculus Go Virtual Reality Goggles for Breast Neoplasm Female. Completed, enrolled 60 participants across 1 site.
Detailed Summary
To determine if a virtual reality simulation will reduce pain and anxiety in patients undergoing an ultrasound guided breast localization procedure (traditional wire, savi scout or a radiofrequency identification tag).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Neoplasm Female
CountriesUnited States
CollaboratorsClemson University
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 2020
Enrollment StartJan 2021
Primary CompletionJan 2022
TodayJul 2026
First PostedFeb 5, 2020
Enrollment StartJan 13, 2021
Primary CompletionJan 7, 2022
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 6.4 years ago
Interventions
Oculus Go Virtual Reality Gogglesdevice
Oculus Go is a standalone portable Virtual Reality device that enables the user to immerse in different virtual environments.Non pharmacological technique to reduce pain and anxiety during a procedure.